Document is current
Any future updates will be listed below
-
Authors
Jin, Ying-Hui
Zhan, Qing-Yuan
Peng, Zhi-Yong
Ren, Xue-Qun
Yin, Xun-Tao
Cai, Lin
Yuan, Yu-Feng
Yue, Ji-Rong
Zhang, Xiao-Chun
Yang, Qi-Wen
Ji, Jianguang
Xia, Jian
Li, Yi-Rong
Zhou, Fu-Xiang
Gao, Ya-Dong
Yu, Zhui
Xu, Feng
Tu, Ming-Li
Tan, Li-Ming
Yang, Min
Chen, Fang
Zhang, Xiao-Ju
Zeng, Mei
Zhu, Yu
Liu, Xin-Can
Yang, Jian
Zhao, Dong-Chi
Ding, Yu-Feng
Hou, Ning
Wang, Fu-Bing
Chen, Hao
Zhang, Yong-Gang
Li, Wei
Chen, Wen
Shi, Yue-Xian
Yang, Xiu-Zhi
Wang, Xue-Jun
Zhong, Yan-Jun
Zhao, Ming-Juan
Li, Bing-Hui
Ma, Lin-Lu
Zi, Hao
Wang, Na
Wang, Yun-Yun
Yu, Shao-Fu
Li, Lu-Yao
Huang, Qiao
Weng, Hong
Ren, Xiang-Ying
Luo, Li-Sha
Fan, Man-Ru
Huang, Di
Xue, Hong-Yang
Yu, Lin-Xin
Gao, Jin-Ping
Deng, Tong
Zeng, Xian-Tao https://orcid.org/0000-0003-1262-725X
Li, Hong-Jun
Cheng, Zhen-Shun
Yao, Xiaomei
Wang, Xing-Huan
,
,
- License Information
-
More Information
Article History
Received: 18 August 2020
Accepted: 25 August 2020
First Online: 4 September 2020
Ethics approval and consent to participate
: The Figs. , , , , , and from existed clinical data from Zhongnan Hospital of Wuhan University, and also approved by the Committee for Ethical Affairs of this hospital and written informed consent was obtained from each participant ([No. 2020074]). No additional ethical approval is needed.
: Not applicable.
: No one reported having stock, being a consultant paid by companies or receiving research funding from companies that have an interest in the guideline. Zhen-Shun Cheng reported participating in or hosting a study of Remdesivir for COVID-19. Ya-Dong Gao reported participating in or hosting two studies of Enteric capsule with diammonium glycyrrhizate combined with vitamin C and hydroxychloroquine for COVID-19. Jian Xia reported participating in or hosting two studies of ECOM treatment for critical patients and a prediction model for COVID-19 prognosis. Qi-Wen Yang reported participating in or hosting a study of clinical evaluation of rapid nucleic acid detection kit. Xiao-Chun Zhang reported participating in or hosting a study of COVID-19 technical research and integrated application projects. Yu-Feng Yuan reported participating in or hosting three studies of Clinical course and prognosis, TCM treatment and rapid disinfection of medical items for COVID-19. Xun-Tao Yin reported participating in or hosting CT imaging diagnosis for COVID-19. Zhui Yu reported participating in or hosting study of treatment for critical COVID-19 patients. Hong-Jun Li reported participating in or hosting study of machine learning for radiology of COVID-19. Xing-Huan Wang leading the favipiravir randomized controlled trial and it was supported by the National Key Research and Development Program of China (2020YFC0844400); Xing-Huan Wang, Xian-Tao Zeng and Ying-Hui Jin reported research projects involving infection of healthcare workers during this epidemic, which was supported by Special Project for Emergency of Hubei Province (2020FCA008). No other disclosures were reported.
